Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children

Completed

Conditions studied: Heart Transplant, Small Intestine Transplant, Kidney Transplant, Liver Transplant, EBV-Related PTLD, PTLDs

In brief

Solid organ transplantation is an important therapeutic option for children with a variety of end stage diseases. However, the same immunosuppressive medications that are required to prevent the child's immune system from attacking and rejecting the transplanted organ can predispose these individuals to developing a very serious cancer that is linked to Epstein-Barr virus (EBV).

Key facts

Study ID
NCT02182986
Run by
National Institute of Allergy and Infectious Diseases (NIAID)
People needed
944
Starts
2014-08-14
Expected to finish
2019-05-15
Last updated by the study team
2019-08-29

Who can join

Age: any, up to 21. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.